MasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules
MasterPharm LLC is recalling compounded Minoxidil/Biotin/Spironolactone capsules due to elevated levels of minoxidil and biotin. The product was distributed in Florida and Maryland.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.
Plain-English summary
MasterPharm LLC is recalling a specific lot of compounded Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsules. The recall was initiated because the product contains elevated levels of minoxidil and biotin, making it a super-potent drug.
The affected product consists of 90-capsule bottles, with a total of 300 capsules involved in the recall. The specific lot number is 01-09-2020:13@8, and the expiration date is July 7, 2020. The product was distributed in Florida and Maryland.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions. The product is a compounded drug not intended for resale.
The recalled product
- Product
- Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Compounded Prescription
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 01-09-2020:13@8
- Exp. 7/7/2020
Distribution
Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Similar recalls
- ModerateMasterPharm Recalls Minoxidil/Biotin/Spironolactone Capsules Due to Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Minoxidil/Biotin Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereMasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
FDA (Drugs) · 2020-05-20
- ModerateMasterPharm Recalls D-Biotin 300 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82F Minoxidil Tretinoin Fluocinolone Acetonide Finasteride
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05